Clinical Trial Update: Celecoxib in Treating Patients With Early-Stage Head and Neck Cancer or Non-Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

This update reports the completion of a Phase 2 trial evaluating celecoxib for early-stage head and neck cancer or non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer
• Non-small Cell Lung Cancer

Drugs mentioned

• Celecoxib (Celecoxib)

Snippet

Sponsor: Northwestern University | Conditions: Head and Neck Cancer, Lung Cancer | Phase 2 | Status: COMPLETED